Molecular approach to breast cancer treatment

This publication has 53 references indexed in Scilit:

• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
  European Journal Of Cancer, 2004
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
  Nature, 2003
• Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
  Cell, 2002
• Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α
  Cell, 2002
• Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
  Oncogene, 2000
• The Hallmarks of Cancer
  Cell, 2000
• ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
  The EMBO Journal, 1997
• Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
  Nature, 1996